Table 5.
KEGG pathway description | N | DE | P.DE | FDR |
---|---|---|---|---|
Male only analysis | ||||
Phagosome | 142 | 5 | 3.85E-05 | 0.002 |
MAPK signaling pathway | 283 | 7 | 6.28E-05 | 0.002 |
AMPK signaling pathway | 117 | 5 | 7.51E-05 | 0.002 |
Focal adhesion | 191 | 6 | 8.16E-05 | 0.002 |
Rap1 signaling pathway | 203 | 6 | 8.60E-05 | 0.002 |
Signaling pathways regulating pluripotency of stem cells | 135 | 5 | 1.35E-04 | 0.003 |
mTOR signaling pathway | 147 | 5 | 1.59E-04 | 0.003 |
Cellular senescence | 153 | 5 | 1.72E-04 | 0.003 |
Phospholipase D signaling pathway | 142 | 5 | 2.07E-04 | 0.003 |
Natural killer cell-mediated cytotoxicity | 105 | 4 | 2.29E-04 | 0.003 |
Female only analysis | ||||
cAMP signaling pathway | 192 | 8 | 9.13E-07 | 1.5E-04 |
Estrogen signaling pathway | 136 | 7 | 9.36E-07 | 1.5E-04 |
Relaxin signaling pathway | 125 | 6 | 1.19E-05 | 0.001 |
Th17 cell differentiation | 102 | 5 | 3.43E-05 | 0.001 |
Wnt signaling pathway | 140 | 6 | 3.54E-05 | 0.001 |
Cell cycle | 121 | 5 | 7.76E-05 | 0.002 |
Platelet activation | 122 | 5 | 9.80E-05 | 0.002 |
B cell receptor signaling pathway | 68 | 4 | 1.20E-04 | 0.003 |
Parathyroid hormone synthesis, secretion, and action | 105 | 5 | 1.21E-04 | 0.003 |
Cytokine-cytokine receptor interaction | 265 | 5 | 2.64E-04 | 0.004 |
N, total genes in the KEGG pathway; DE, the number of genes within the CpGs with p < 0.0001; FDR, FDR-adjusted p-value for enrichment.